A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is โฉ272,504.28, with a 24-hour trading volume of โฉ298.09B. The asset's market cap is โฉ422.96T, after moving -1.50% in the last day.
Tokenized AstraZeneca PLC is trading at โฉ153,709.35, with a tokenized market cap of โฉ87.02B and a 24-hour trading volume of โฉ1.11B. The tokenized asset has moved 11.64% in the past 24 hours.